CONDENSED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
OPERATING EXPENSES
Research and development	$ 3,680	$ 2,660
General and administrative	1,888	1,736
OPERATING LOSS	(5,568)	(4,396)
Finance income	236	225
NET LOSS	(5,332)	(4,171)
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	$ (5,332)	$ (4,171)
BASIC NET LOSS PER COMMON SHARE OUTSTANDING, see Note 6	$ (0.27)	$ (0.25)
DILUTED NET LOSS PER COMMON SHARE OUTSTANDING, see Note 6	$ (0.27)	$ (0.25)
Basic weighted average number of common shares outstanding	19,937,507	16,559,335
Diluted weighted average number of common shares outstanding	19,937,507	16,559,335